Back

PAD patients present with poorer lipid target attainment than polyvascular patients - a call for intensified treatment

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Peripheral Vascular and Cerebrovascular Disease ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Meisam Khorrami Borozadi

Lucerne Cantonal Hospital, Luzern (Switzerland)

44 More presentations in this session

Presentation thumbnail
Atlas of the immune cell repertoire in human atherosclerotic plaques characterized by single cell RNA-sequencing and multi-color flow cytometry
Mr H. Horstmann (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Peripheral artery disease impairs myocardial perfusion through increasing pulse wave reflection: The Northern Shanghai Study
Doctor S. Yu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in a cohort of patients with peripheral arterial disease. A retrospective study of a healthcare database in UK.
Mr A. Vitalis (Colchester, GB)
Abstract Slides
Presentation thumbnail
Prevalence, specialized ambulatory care and guideline-recommended therapy of peripheral vascular diseases in Germany
Mrs O. Petrikhovich (Essen, DE)
Abstract Slides
Presentation thumbnail
Clinical impact of peripheral artery disease on acute coronary syndrome
Doctor F. Fonseca Goncalves (Vila Real, PT)
Abstract Slides

Access the full session

Session thumbnail
Peripheral Vascular and Cerebrovascular Disease ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022
thumbnail
Congress Presentation
Association of body mass index with non-achievement of target low-density lipoprotein level in older patients at very high cardiovascular risk: a multicentre study
27 August 2021
thumbnail
Congress Presentation
Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort
27 August 2021
thumbnail
Congress Presentation
Extension of coronary artery disease and resistance to lipid-lowering treatment. Value of Lp(a)
23 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources